Jaguar Health, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $11.5M | $11.7M | $9.8M | $12.0M | $4.3M |
| Operating income | -$45.9M | -$30.8M | -$34.3M | -$34.4M | -$40.7M |
| Cost of revenue | $97,000 | $2.0M | $2.0M | $2.0M | $2.3M |
| Cash from operations | -$23.7M | -$29.4M | -$33.2M | -$33.1M | -$35.0M |
| Capital expenditure | $41,000 | $16,000 | — | $77,000 | $6,000 |
| Free cash flow | -$23.7M | -$29.4M | — | -$33.2M | -$35.0M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $38.3M | $53.4M | $50.8M | $47.5M | $53.3M |
| Total liabilities | $57.0M | $44.4M | $45.9M | $48.8M | $41.4M |
| Total debt | — | — | — | $6.2M | $6.2M |
Shares outstanding 603.1K
Annual filing data through FY ended December 31, 2025; float as of July 2, 2026.